South & Central America Enteral Medical Nutrition Market Forecast to 2028 – COVID

South & Central America Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]

Report Code : BMIRE00027545 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 23/Nov/2022

The enteral medical nutrition market in South & Central America is expected to grow from US$ 435.35 million in 2022 to US$ 625.02 million by 2028. It is estimated to grow at a CAGR of 6.2% from 2022 to 2028.

Use of Next Generation Technology for Proper Enteral Nutrition Feeding

In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period.

Market Overview

SAM enteral medical nutrition market includes Brazil, Argentina, and Rest of SAM. The region held smallest portion of the market in the global analysis. The market for enteral medical nutrition in the region is expected to have growth opportunities during the forecast period. The enteral medical nutrition market in the SAM region is expected to grow owing to factors such as, an increase in cases of neurological diseases in the region, increasing awareness, and rising healthcare expenditure by the countries of the region.

The increasing prevalence of chronic diseases, such as cancer and diabetes, drives the growth of the enteral medical nutrition market in Brazil. The average prevalence of diabetes in Brazil is 8.0% and is expected to reach 9.8% by 2035. This rising diabetes prevalence has translated into a 60% growth in the related risk ratio for cardiovascular diseases associated with diabetes. This is likely to increase the demand for enteral nutrition in the treatment of the patients.

In addition, the prevalence of neurological disorders has been linked with the aging population in Brazil. The World Health Organization and the Brazilian Institute of Geography and Statistics reported that the geriatric population in Brazil (aged ≥ 60 years) will reach ~55 million by 2040. The rising number of geriatric population is expected to increase the incidence of chronic neurological disorders in the coming years and this increase in the neurological diseases will propel the demand for enteral medical nutrition.

South & Central America Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Enteral Medical Nutrition Market Segmentation

The South & Central America enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country.

Based on indication, the South & Central America enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment is expected to hold the largest share in 2022. Based on nutrition type, the South & Central America enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment is expected to hold the largest share of the market in 2022. Based on form, the South & Central America enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment is expected to hold the largest share of the market in 2022. Based on product, the South & Central America enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment is expected to hold largest share of the market in 2022. Based on distribution channel, the South & Central America Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment is expected to hold the largest share of the market in 2022. Based on Age Group, the South & Central America enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment is expected to hold largest share of the market in 2022. Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America is expected to hold the largest market share in 2022. Abbott Laboratories; B. Braun MelsungenAG; DSMNutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.

At 6.2% CAGR, the South & Central America Enteral Medical Nutrition Market is speculated to be worth US$ 625.02 Million by 2028, says The Insight Partners

According to The Insight Partners’ research, the South & Central America enteral medical nutrition market was valued at US$ 435.35 million in 2022 and is expected to reach US$ 625.02 million by 2028, registering an annual growth rate of 6.2% from 2022 to 2028. Use of next generation technology for proper enteral nutrition feeding is the critical factor attributed to the market expansion.

In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period.

On the contrary, complications of enteral nutrition hurdle the growth of South & Central America enteral medical nutrition market.

Based on indication, the South & Central America enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. Respiratory disorders held 41.4% market share in 2022, amassing US$ 180.43 million. It is projected to garner US$ 252.69 million by 2028 to expand at 5.8% CAGR during 2022–2028. Based on nutrition type, the South & Central America enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 76.2% market share in 2022, amassing US$ 331.80 million. It is projected to garner US$ 470.77 million by 2028 to expand at 6.0% CAGR during 2022–2028. Based on form, the South & Central America enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held 55.1% market share in 2022, amassing US$ 240.00 million. It is projected to garner US$ 351.56 million by 2028 to expand at 6.6% CAGR during 2022–2028. Based on product, the South & Central America enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held 52.5% market share in 2022, amassing US$ 228.58 million. It is projected to garner US$ 322.92 million by 2028 to expand at 5.9% CAGR during 2022–2028. Based on distribution channel, the South & Central America Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held 60.7% market share in 2022, amassing US$ 264.28 million. It is projected to garner US$ 377.14 million by 2028 to expand at 6.1% CAGR during 2022–2028.

Based on Age Group, the South & Central America enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). With 89.7% share of the domain, the adults segment dominated the market in 2022. It accrued US$ 390.44 million in 2022 and is estimated to generate US$ 556.61 million by 2028 to grow at a CAGR of 6.1% over the forecast period. Our regional analysis states that Rest of SAM captured 38.0% market share in 2022. It was assessed at US$ 165.57 million in 2022 and is likely to hit US$ 233.19 million by 2028, exhibiting a CAGR of 5.9% during the forecast period.

Key players dominating the South & Central America enteral medical nutrition market are Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Enteral Medical Nutrition Market – By Indication

1.3.2 SAM Enteral Medical Nutrition Market – By Nutrition Type

1.3.3 SAM Enteral Medical Nutrition Market – By Form

1.3.4 SAM Enteral Medical Nutrition Market – By Product

1.3.5 SAM Enteral Medical Nutrition Market – By Distribution Channel

1.3.6 SAM Enteral Medical Nutrition Market – By Age Group

1.3.7 SAM Enteral Medical Nutrition Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Enteral Medical Nutrition Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Enteral Medical Nutrition Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Cachexia

5.1.2 Rise in Prevalence of Gastrointestinal Diseases

5.2 Market Restraints

5.2.1 Complications of Enteral Nutrition

5.3 Market Opportunities

5.3.1 Use of Next Generation Technology for Proper Enteral Nutrition Feeding

5.4 Future Trends

5.4.1 Developments Related to Enteral Medical Nutrition Products

5.5 Impact Analysis

6. Enteral Medical Nutrition Market – SAM Analysis

6.1 SAM Enteral Medical Nutrition Market Revenue Forecast and Analysis

7. Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Indication

7.1 Overview

7.2 SAM Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)

7.3 Respiratory Disorders

7.3.1 Overview

7.3.2 Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)

7.3.3 Chronic Obstructive Pulmonary Disease

7.3.3.1 Overview

7.3.3.2 Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)

7.3.4 Respiratory Failure

7.3.4.1 Overview

7.3.4.2 Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)

7.3.5 Cystic Fibrosis

7.3.5.1 Overview

7.3.5.2 Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)

7.3.6 Others

7.3.6.1 Overview

7.3.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer

7.4.1 Overview

7.4.2 Cancer Market Revenue and Forecast to 2028 (US$ Million)

7.4.3 Cancer Cachexia

7.4.3.1 Overview

7.4.3.2 Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)

7.4.4 Cachexia with COPD

7.4.4.1 Overview

7.4.4.2 Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)

7.4.5 Others

7.4.5.1 Overview

7.4.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)

7.5 Post COVID-19

7.5.1 Overview

7.5.2 Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)

7.6 Gastrointestinal Disorders

7.6.1 Overview

7.6.2 Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Bowel Obstruction

7.6.3.1 Overview

7.6.3.2 Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Crohn’s Disease

7.6.4.1 Overview

7.6.4.2 Crohn’s Disease Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Short Bowel Syndrome

7.6.5.1 Overview

7.6.5.2 Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Others

7.6.6.1 Overview

7.6.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

7.7 Liver Failure

7.7.1 Overview

7.7.2 Liver Failure Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Other Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Nutrition Type

8.1 Overview

8.2 SAM Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)

8.3 Supplemental

8.3.1 Overview

8.3.2 Supplemental Market Revenue and Forecast to 2028 (US$ Million)

8.4 Sole-Source

8.4.1 Overview

8.4.2 Sole-Source Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Form

9.1 Overview

9.2 SAM Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)

9.3 Powder

9.3.1 Overview

9.3.2 Powder Market Revenue and Forecast to 2028 (US$ Million)

9.4 Liquid

9.4.1 Overview

9.4.2 Liquid Market Revenue and Forecast to 2028 (US$ Million)

9.5 Semi-Solid

9.5.1 Overview

9.5.2 Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Product

10.1 Overview

10.2 SAM Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)

10.3 Standard Protein Diet

10.3.1 Overview

10.3.2 Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)

10.4 High Protein Diet

10.4.1 Overview

10.4.2 High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)

10.5 Fruit Juice Based Oral Nutritional Supplement

10.5.1 Overview

10.5.2 Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Other Market Revenue and Forecast to 2028 (US$ Million)

11. SAM Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Distribution Channel

11.1 Overview

11.2 SAM Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)

11.3 Hospital Pharmacies

11.3.1 Overview

11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.4 Retail Pharmacies

11.4.1 Overview

11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. SAM Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Age Group

12.1 Overview

12.2 SAM Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)

12.3 Child (Till 18 Years)

12.3.1 Overview

12.3.2 Child Market Revenue and Forecast to 2028 (US$ Million)

12.4 Adult (Above 18+ Years)

12.4.1 Overview

12.4.2 Adult Market Revenue and Forecast to 2028 (US$ Million)

13. SAM Enteral Medical Nutrition Market Revenue and Forecasts to 2028 – Country Analysis

13.1 Overview

13.1.1 SAM: Enteral Medical Nutrition Market, by Country, 2022 & 2028 (%)

13.1.1.1 Brazil: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.1 Overview

13.1.1.1.2 Brazil: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.3 Brazil: Enteral Medical Nutrition Market, by Indication, 2019–2028 (USD Million)

13.1.1.1.3.1 Brazil: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019–2028 (USD Million)

13.1.1.1.3.2 Brazil: Enteral Medical Nutrition Market, by Cancer, 2019–2028 (USD Million)

13.1.1.1.3.3 Brazil: Enteral Medical Nutrition Market, by Gastrointestinal Disorders , 2019–2028 (USD Million)

13.1.1.1.4 Brazil: Enteral Medical Nutrition Market, by Nutrition Type, 2019–2028 (USD Million)

13.1.1.1.5 Brazil: Enteral Medical Nutrition Market, by Form, 2019–2028 (USD Million)

13.1.1.1.6 Brazil: Enteral Medical Nutrition Market, by Product, 2019–2028 (USD Million)

13.1.1.1.7 Brazil Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.8 Brazil Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

13.1.1.2 Argentina: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.1 Overview

13.1.1.2.2 Argentina: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.3 Argentina: Enteral Medical Nutrition Market, by Indication, 2019–2028 (USD Million)

13.1.1.2.3.1 Argentina: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019–2028 (USD Million)

13.1.1.2.3.2 Argentina: Enteral Medical Nutrition Market, by Cancer, 2019–2028 (USD Million)

13.1.1.2.3.3 Argentina: Enteral Medical Nutrition Market, by Gastrointestinal Disorders , 2019–2028 (USD Million)

13.1.1.2.4 Argentina: Enteral Medical Nutrition Market, by Nutrition Type, 2019–2028 (USD Million)

13.1.1.2.5 Argentina: Enteral Medical Nutrition Market, by Form, 2019–2028 (USD Million)

13.1.1.2.6 Argentina: Enteral Medical Nutrition Market, by Product, 2019–2028 (USD Million)

13.1.1.2.7 Argentina Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.8 Argentina Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

13.1.1.3 Rest of SAM: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.1 Overview

13.1.1.3.2 Rest of SAM: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.3 Rest of SAM: Enteral Medical Nutrition Market, by Indication, 2019–2028 (USD Million)

13.1.1.3.3.1 Rest of SAM: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019–2028 (USD Million)

13.1.1.3.3.2 Rest of SAM: Enteral Medical Nutrition Market, by Cancer, 2019–2028 (USD Million)

13.1.1.3.3.3 Rest of SAM: Enteral Medical Nutrition Market, by Gastrointestinal Disorders , 2019–2028 (USD Million)

13.1.1.3.4 Rest of SAM: Enteral Medical Nutrition Market, by Nutrition Type, 2019–2028 (USD Million)

13.1.1.3.5 Rest of SAM: Enteral Medical Nutrition Market, by Form, 2019–2028 (USD Million)

13.1.1.3.6 Rest of SAM: Enteral Medical Nutrition Market, by Product, 2019–2028 (USD Million)

13.1.1.3.7 Rest of SAM Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.8 Rest of SAM Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

14. Enteral Medical Nutrition Market– Industry Landscape

14.1 Overview

14.2 Growth Strategies Done by the Companies in the Market, (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Abbott Laboratories

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 Nutricia

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Fresenius Kabi AG

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 B. Braun Melsungen AG

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Nestlé S.A.

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Meiji Holdings Co., Ltd.

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 Smartfish AS

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 DSM Nutritional Products AG

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 Hormel Foods Corporation

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 Global Health Products, Inc.

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms in Enteral Medical Nutrition Market

LIST OF TABLES.

Table 1. Brazil: Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 2. Brazil Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)

Table 5. Brazil: Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)

Table 6. Brazil: Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)

Table 7. Brazil: Enteral Medical Nutrition Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8. Brazil Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 9. Brazil Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 10. Argentina: Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 11. Argentina Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)

Table 12. Argentina Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)

Table 13. Argentina Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)

Table 14. Argentina: Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)

Table 15. Argentina: Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)

Table 16. Argentina: Enteral Medical Nutrition Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 17. Argentina Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 18. Argentina Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of SAM: Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of SAM Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of SAM Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of SAM Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of SAM: Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of SAM: Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)

Table 25. Rest of SAM: Enteral Medical Nutrition Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 26. Rest of SAM Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of SAM Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)

Table 28. Organic Developments Done By Companies

Table 29. Inorganic Developments Done By Companies

Table 30. Glossary of Terms in SAM Enteral Medical Nutrition Market

LIST OF FIGURES.

Figure 1. SAM Enteral Medical Nutrition Market Segmentation

Figure 2. SAM Enteral Medical Nutrition Market, By Country

Figure 3. SAM Enteral Medical Nutrition Market Overview

Figure 4. Respiratory Disorders Segment Held Largest Share of Indication Segment in SAM Enteral Medical Nutrition Market

Figure 5. Argentina is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. SAM: PEST Analysis

Figure 7. Experts Opinion

Figure 8. SAM Enteral Medical Nutrition Market– Revenue Forecast and Analysis – 2019- 2028

Figure 9. SAM Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)

Figure 10. SAM Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)

Figure 11. SAM Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. SAM Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. SAM Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. SAM Cancer Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. SAM Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)

Figure 17. SAM Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)

Figure 18. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. SAM Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. SAM Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. SAM Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Crohn’s Disease Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. Liver Failure Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. SAM Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)

Figure 28. Supplemental Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Sole-Source Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. SAM Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)

Figure 31. SAM Powder Market Revenue and Forecast to 2028 (US$ Million)

Figure 32. SAM Liquid Market Revenue and Forecast to 2028 (US$ Million)

Figure 33. SAM Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)

Figure 34. SAM Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)

Figure 35. SAM Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)

Figure 36. SAM High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)

Figure 37. SAM Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)

Figure 38. SAM Other Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. SAM Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)

Figure 40. SAM Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 41. SAM Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 42. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 43. SAM Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)

Figure 44. SAM Child Market Revenue and Forecast to 2028 (US$ Million)

Figure 45. SAM Adult Market Revenue and Forecast to 2028 (US$ Million)

Figure 46. SAM: Enteral Medical Nutrition Market, by Key Country – Revenue (2022) (USD Million)

Figure 47. SAM: Enteral Medical Nutrition Market, by Country, 2022 & 2028 (%)

Figure 48. Brazil: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Argentina: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Rest of SAM: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - South & Central America Enteral Medical Nutrition Market

● Abbott Laboratories

● B. Braun Melsungen AG

● DSM Nutritional Products AG

● Fresenius Kabi AG

● Global Health Products, Inc.

● Hormel Foods Corporation

● Meiji Holdings Co., Ltd.

● Nestlé S.A.

● Nutricia

● Smartfish AS

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America enteral medical nutrition market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the South & Central America enteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the enteral medical nutrition market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

TOP